MetaCap

Contineum Therapeutics (CTNM) Stock Chart

NASDAQ: CTNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.73+0.08 (+0.63%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CTNM technical summary

CTNM is trading 14.0% below its 50-day simple moving average of $14.81 and 7.3% below its 200-day average of $13.73. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 41.6, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $8.60 (Jan 8, 2026) to $17.79 (Sep 3, 2026); the current price sits 45% of the way from the low to the high. Annualized 30-day volatility is 71.8%. Based on the last session's high, low and close, the classic pivot point is $12.68, with first resistance at $13.06 and first support at $12.36.

These indicators describe past price behavior for Contineum Therapeutics; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
17.79 (Sep 3)
1Y low
8.60 (Jan 8)
Last close
12.73

CTNM price performance

1 week

-5.14%

1 month

-20.14%

3 months

-18.66%

6 months

-0.47%

Year to date

+11.37%

1 year

+11.76%

CTNM price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day12.84Price below12.77Price below
10-day12.69Price above12.89Price below
20-day13.25Price below13.40Price below
50-day14.81Price below14.13Price below
100-day14.17Price below14.12Price below
200-day13.73Price below13.57Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)13.76
Resistance 2 (R2)13.38
Resistance 1 (R1)13.06
Pivot point12.68
Support 1 (S1)12.36
Support 2 (S2)11.98
Support 3 (S3)11.66

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis